newsnews

Novasep and GTP Technology join forces to ease production of mAbs and recombinant proteins

Partnership offers biotech firms full CDMO services at all development stages from gene to end product

Novasep and GTP Technology join forces to ease production of mAbs and recombinant proteins

Lyon and Toulouse, France, March 21, 2016 – Novasep, a leading supplier of services and technologies for the life sciences industry, and GTP (Gene-to-Proteins) Technology, a CDMO providing recombinant protein and process development services, today announce a partnership that combines their expertise in monoclonal antibodies (mAbs) production. The partners aim to facilitate the development of therapeutic and diagnostic candidates for European biopharmaceutical clients.

Read more